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Summary
Objective: The purpose of this trial was to determine the spectrum of diseases with fever of
unknown origin (FUO) in Turkey.
Methods: A prospective multicenter study of 154 patients with FUO in twelve Turkish tertiary-
care hospitals was conducted.
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Results: The mean age of the patients was 42  17 years (range 17—75). Fifty-three (34.4%) had
infectious diseases (ID), 47 (30.5%) had non-infectious inflammatory diseases (NIID), 22 (14.3%) had
malignant diseases (MD), and eight (5.2%) had miscellaneous diseases (Mi). In 24 (15.6%) of the
cases, the reason for high fever could not be determined despite intensive efforts. The most
common ID etiologies were tuberculosis (13.6%) and cytomegalovirus (CMV) infection (3.2%). Adult
Still’s disease was the most common NIID (13.6%) and hematological malignancy was the most
common MD (7.8%). In patients with NIID, the mean duration of reaching a definite diagnosis
(37  23 days) was significantly longer compared to the patients with ID (25  12 days) (p = 0.007).
In patients with MD, the mean duration of fever (51  35 days) was longer compared to patients
with ID (37  38 days) (p = 0.052).
Conclusions: Although infection remains the most common cause of FUO, with the highest
percentage for tuberculosis, non-infectious etiologies seem to have increased when compared
with previous studies.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The spectrum of diseases causing fever of unknown origin
(FUO) not only seems to be determined by the geographic
region, age of the patient, type of healthcare facility, and
socioeconomic status of the country, but also appears to be
changing over time owing to the net effect of complex inter-
actions between all these parameters.1,2 Thus, clinicians may
find it difficult to establish the entire spectrum of diseases
causing FUO. A satisfactory standardization has not yet been
achieved, because studies in this area have used either a
retrospective design3,4 or variable diagnostic criteria.5,6
Although some suggestions have been made on diagnosis,
it has been impossible to extrapolate these approaches.7—9
Prospective studies performed using uniform criteria have
failed to provide a satisfactory methodology for FUO cases in
developing countries where diagnostic tools are usually una-
vailable. In Turkey, in particular, failure to implement stan-
dardized diagnostic criteria in studies performed so far, and
the lack of prospective multicenter studies, have precluded
comprehensive evaluations of the current situation in the
country as a whole.
This study was performed prospectively to obtain more
comprehensive data on FUO throughout the country in order
to establish the changing spectrum of FUO and to determine
diagnostic clues by using objective criteria in healthcare
settings such as tertiary-care hospitals, where conventional
modern diagnostic tools are more commonly used.
Patients and methods
This study was conducted prospectively in twelve Turkish
tertiary-care hospitals between January 2003 and June 2004.
Medical records of all patients with an initial diagnosis of FUO
were retrieved from a computer database generated for this
study. All cases were followed up in a hospital setting and
written informed consent was obtained. Patients enrolled in
this study were older than 18 years of age and fulfilled the
modified Petersdorf criteria of FUO.10,11 These criteria are:
(1) a temperature exceeding 38.3 8C; (2) duration of the
fever of more than three weeks; (3) evaluation of three
outpatient visits or three days in hospital.
Initially, patient complaints along with personal and family
histories, travel history, occupation, and results of physicalexam were noted. At least two blood cultures were obtained
fromtwodifferent extremities ata 30-minute interval for each
patient during the fever episode. Patients with non-diagnostic
initial laboratory tests underwent further laboratory testing.
Symptoms and signs of all patients were recorded. The same
attending physicians performed regular visits to evaluate daily
changes for all patients. Thediagnosticprotocolwasapplied to
all patients (Table 1). Abnormal tests were subdivided into
‘contributing’ and ‘non-contributing’. The cause of FUO was
determined at the time of discharge or during follow-up. The
causes were classified into five groups: (1) infectious diseases
(ID), (2) malignant diseases (MD), (3) non-infectious inflam-
matory diseases (NIID), (4) miscellaneous (Mi), and (5) undiag-
nosed (U).
The day of hospital admission was nominated as the first
day for the follow-up of symptoms and signs. Clinical and
laboratory data obtained before admissionwere used only as
complementary data. Evaluation of the course of fever was
also started from the day of admission. Patients ceased using
any antibiotics or antipyretics on the admission day.
Statistical analysis
Most variables showed non-normal distribution, thus non-
parametrical methods were used in all analyses. Values were
compared using Kruskal—Wallis non-parametric ANOVA. The
patients were dichotomized into diagnosis groups (i.e.,
patients with or without ‘infection’, etc.) and then mean
values were compared using the Mann—Whitney U test.
Group percentages were compared using contingency
table analyses, Chi-square test, Fisher’s exact test, and
Mantel—Haenszel test. The association between factors
and diagnoses were analyzed by means of multivariate logis-
tic regression analysis. A value of p < 0.05 was considered
significant, except in stepwise logistic regression models. For
the latter, a value of p < 0.10 was considered significant. No
adjustments were done for multiple tests.
Results
During the study period, 154 patients meeting the FUO
criteria were evaluated in 12 tertiary-care hospitals. The
mean age of the patients was 42  17 years (range 17—75).
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Table 1 Diagnostic protocol
Complaints
History
Personal history
Family history
Evaluation of systems
Physical exam
Appropriate tests if there are any diagnostic clues
If no clues, start diagnostic workup with first-line tests
No diagnosis with first-line tests, continue with second-line tests
Definitive diagnosis with positive serology or positive
culture or histology
In some patients:
by excluding other diseases
by a response to specific treatment, or
by observing the course of the disease
Definitive diagnosis made by the attending physician or by the consultants he/she has chosen
The time and type of diagnosis recorded. Number and time of tests and radiographic methods checked in patient files
Patients with no definitive diagnosis followed up, even after discharge, for 6 months
Daily physicals continue during diagnostic work-up with recording of any changes that occur
Phase 1 diagnostic protocol:
Complete blood count with differential, ESR, CRP, RF, ASO, CMV IgM, EBV IgM, urinanalysis, HBsAg, glucose, uric acid,
AST, ALT, GGT, LDH, ALP, T-bilirubin, D-bilirubin, albumin, T-protein, BUN, creatinine, Na, K, Ca, CPK, ANA, ds-DNA,
TSH, PPD, Brucella agglutination, Salmonella agglutination, cultures of blood, urine, stool, and sputum, stool microscopy,
AARB in sputum, chest X-ray, abdominopelvic US
Phase 2 diagnostic protocol:
Protein electrophoresis, amylase, ACE, ANCA, IgG, IgA, IgM, ENA panel, C3, C4, cryoglobulin, T3, T4, Mycoplasma
cell culture, Toxoplasma cell culture, Treponoma, Yersinia cell cultures, lymph node biopsy and culture, liver biopsy,
temporal artery biopsy, thyroid biopsy, VMA in 24-hour-urine, thyroglobulin, antimicrosomal antibody, PSA, HIV, HCV,
plasma cortisol, echocardiography, abdomino-pelvic CT, chest CT, rectosigmoidoscopy, barium enema, sinus X-ray,
dental exam, fundic exam, leukocyte scan, laparoscopy, laparatomy
Phase 3 diagnostic protocol:
Invasive procedures: all kinds of biopsies, laparoscopy/laparatomy, endoscopic examinations
Non-invasive procedures: hematologic, serologic tests, cultures, radiologic examinations
AARB, acid—alcohol resistant bacilli; ACE, angiotensin-converting enzyme; ALP, alkaline phosphatase; ALT, alanine aminotransferase; ANA,
antinuclear antibody; ANCA, anti-neutrophil cytoplasmic antibodies; ASO, antistreptolysin O; AST, aspartate aminotransferase; BUN, blood
urea nitrogen; C3, C4, complement; CMV, cytomegalovirus; CPK, creatinine phosphokinase; CRP, C-reactive protein; CT, computerized
tomography; D-bilirubin, direct bilirubin; ds-DNA, double-stranded DNA; EBV, Epstein—Barr virus; ENA, extractable nuclear antigen; ESR,
erythrocyte sedimentation rate; GGT, g-glutamyl transpeptidase; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HIV, human
immunodeficiency virus; LDH, lactate dehydrogenase; PPD, purified protein derivative; PSA, prostate-specific antigen; RF, rheumatoid
factor; T3, triiodothryronine; T4, thyroxine; T-bilirubin, total bilirubin; T-protein, total protein; TSH, thyroid stimulating hormone; US,
ultrasound; VMA, vanillylmandelic acid.Eighty-three (53.9%) patients were male and 71 (46.1%) were
female. The final diagnoses are shown in Table 2.
Themean duration of fever in patients in whom a diagnosis
was established was 35  32 days (range 13—180). In patients
with MD, the mean duration of fever (51  35) was longer
than for those with ID (37  38) ( p = 0.052), although this
difference was not statistically significant. Themean interval
between admission and diagnosis was 32  18 days (range 4—
90 days). In NIID patients this interval (37  23) was signifi-
cantly longer than in patients with ID (25  12) ( p = 0.007).
The most common risk factors in our cases were previous
use of antibiotics, history of cigarette smoking, and pre-
vious diseases. Compared to other groups, a history of pre-
vious antibiotic use was significantly more common in the Mi
group ( p = 0.027).Symptoms and signs
The most common symptoms were fever (100%), fatigue
(80%), chills (67%), weight loss (62%), myalgia (44%), and
arthralgia (4%). Weakness was observed significantly more
frequently in the MD and ID groups ( p = 0.019 and p = 0.013,
respectively). In NIID and MD groups, arthralgia was more
common than in the others ( p = 0.015 and p = 0.001, respec-
tively).
The mean value of fever was 38.3  0.3 8C at the first
examination with no significant difference between the
groups. The most common physical findings were cardiac
murmur (27%), hepatomegaly (23%), lymphadenomegaly
(22%), skin rash (16%), splenomegaly (15%), and arthritis
(13%).
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Table 2 The final diagnosis in patients with fever of unknown origin
Infectious diseases (53) Malignant diseases (22) Non-infectious inflammatory
diseases (47)
Miscellaneous (8)
Tuberculosis (21) Hematological malignancies (12) Collagen tissue disease (31) Drug fever (2)
Pulmonary tuberculosis (6) Hodgkin lymphoma (4) Adult Still’s disease (21) FMF (2)
Disseminated tuberculosis (5) Non-Hodgkin lymphoma (1) Subacute thyroiditis (3) Ulcerative colitis (1)
Tuberculosis lymphadenitis (5) Splenic lymphoma (2) SLE (2) Crohn’s disease (1)
Pleural tuberculosis
lymphadenitis (2)
Multiple myeloma (2) Dermatomyositis (1) Thrombosis (1)
Pericardial tuberculosis (1) CML (1) Rheumatoid arthritis (1) Gout (1)
Renal tuberculosis (1) MDS (1) Polymyositis (1)
Peritoneal tuberculosis (1) AML (1) Polymyalgia rheumatica (1)
Other (32) Solid cancer (10) Interstitial pulmonary fibrosis (1)
CMV pneumonia (5) Adenocarcinoma (2) Vasculitis (14)
Abscesses (5) Stromal tumor (1) Unclassified vasculitis (5)
Brucellosis (5) Hypernephroma (1) Temporal arteritis (4)
Toxoplasmosis (4) Castleman disease (1) PAN (3)
Salmonellosis (3) Metastatic carcinoma (1) HSP (2)
Pyelonephritis (2) Testis tumor (1) Granulomatous disease (2)
PID (2) Colon carcinoma (1) Sarcoidosis (2)
Urinary infection (2) Pancreatic carcinoma (1)
Endocarditis (1) Gastric carcinoma (1)
Systemic candidiasis (1)
Leptospirosis (1)
Meningitis (1)
Undiagnosed (24)
CMV, cytomegalovirus; PID, pelvic inflammatory disease; CML, chronic myeloid leukemia; MDS, myelodysplastic syndrome; AML: acute
myeloid leukemia; SLE, systemic lupus erythematosus; PAN, polyarteritis nodosa; HSP, Henoch—Scho¨nlein purpura; FMF, familial Medi-
terranean fever.Biochemical techniques
The most frequent chemical findings were elevated erythro-
cyte sedimentation rate (ESR) (88%), elevated C-reactive pro-
tein (CRP) (80%), elevated g-glutamyl transpeptidase (GGT)
(68%), anemia (64%), and leukocytosis (50%) (Table 3). Initially
2978 biochemical tests were performed. Of 1080 positive
biochemical tests, only 18 (1.7%) contributed indirectly to
diagnosis.
Microbiologic serology
Sixteen of 752 serologic tests yielded significant results for a
definite diagnosis. The diseases most commonly diagnosed by
serologic tests were cytomegalovirus (CMV) infections, bru-
cellosis, salmonellosis, and Mycoplasma pneumoniae infec-
tions. CMV seropositivity was identified in five cases. In four
of these patients mononucleosis-like clinical presentation
was observed, and two of them also had histopathologic
findings concordant with CMV. Successive serologic tests
repeated at 10-day intervals revealed a course of IgM- and
IgG-type antibodies, which was compatible with acute infec-
tion. In all patients with positive Mycoplasma serology, pul-
monary findings were identified either before or shortly after
the diagnosis. All cases had atypical pneumonia. Our salmo-
nellosis cases came to us very late and possibly after the
bacteremic period; cultures were negative, albeit the ser-
ology was positive with high titers.Immunologic serology
Of the 156 immunoserologic tests, 20 yielded positive results
and eight of these were considered ‘contributing’. The
results of the immunologic examinations were as follows
(positive results/number of tests): antinuclear antibody
(ANA; 10/145), double-stranded DNA (ds-DNA; 2/94), rheu-
matoid factor (RF; 2/48), extractable nuclear antigen (ENA;
4/38), angiotensin-converting enzyme (ACE; 1/14), perinuc-
lear anti-neutrophil cytoplasmic antibodies (p-ANCA; 1/9),
and immunoelectrophoresis (-/8). ANA and ds-DNA were
helpful in establishing the diagnosis of systemic lupus erythe-
matosus (SLE; n = 2), whereas RF was helpful in diagnosing
vasculitis in rheumatoid arthritis.
Culture techniques
From 514 cultures obtained from all patients the following
results were revealed (positive results/number of tests):
blood (8/154), urine (7/154), sputum (4/128), stool (1/
22), wound (4/15), catheter (2/12), pleural fluid (2/10),
cerebrospinal fluid (-/10), and peritoneal fluid (-/9). Results
of 12 cultures (six blood, three urine, two sputum, one
pleural fluid) revealed the final diagnosis.
In six patients, blood cultures were used to establish the
diagnosis: abscesses in three patients, pneumonia with bac-
teremia in two patients, and tuberculosis in one patient. In
four patients, false-positive blood cultures were obtained by
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Table 3 Laboratory findings
N (%) ID % MD % NIID % Mi % U % p
ESR >20 mm/h 136 (88) 81 90 100a 92 75b ap = 0.003
bp = 0.027
ESR (mean  SD) 76  38 75  39 70  42 88  32a 46  9b 73  41 ap = 0.019
bp = 0.011
CRP >6 mg/dl 124 (80) 79 77 82 75 83 NS
CRP (mean  SD) 50  59 49  61 29  49a 64  63b 47  63 42  49 ap = 0.019
bp = 0.006
GGT >50 U/l 102 (68) 71 71 71 71 16a ap = 0.039
Anemia <12 g/dl 100 (64) 64 72 62 20 87a ap = 0.027
Hb g/dl 10.7 10.7 9.7b 10.9 13.4a 10.4 ap = 0.001
bp = 0.027
Leukocytosis >10  109/l 78 (50) 42 63 65a 75 20b ap = 0.001
bp = 0.001
Leukocyte count (109/l) 12.956 10.519 21.977 13.845 10.905 9.149 NS
ALP >160 U/L 74 (48) 55 54 47 12 37 NS
BUN >20 mg/dl 67 (43) 50 54 43 50 16a ap = 0.004
LDH >450 U/l 62 (40) 42 40 37 12 50 NS
LDH (mean  SD) 505  381 502  364 651  535a 441  203 447  127 ap = 0.035
Hyperuricemia 38 (40) 58a 28 47 0 12b ap = 0.038
bp = 0.012
ALT >40 U/l 57 (37) 42 45 39 25 16a ap = 0.025
ALT (mean  SD) 48  59 42  36 65  92 51  66 26  20 44  57 NS
AST >40 U/l 53 (34) 39 36 34 25 25 NS
Proteinuria 38 (24) 26 18 30 25 NS
Total bilirubin >1 mg 18 (13) 15 10 13 8 NS
Hematuria 14 (9) 7 13 25 8 NS
CPK >190 U/l 10 (6) 2 4 13a 12 4 ap = 0.031
ID, infectious diseases; MD, malignant diseases; NIID, non-infectious inflammatory diseases; Mi, miscellaneous; U, undiagnosed; ESR,
erythrocyte sedimentation rate; CRP, C-reactive protein; GGT, g-glutamyl transpeptidase; Hb, hemoglobin; ALP, alkaline phosphatase; BUN,
blood urinary nitrogen; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatinine
phosphokinase; NS, not significant.the growth of coagulase-negative staphylococci. Urinary cul-
tures were helpful in establishing the diagnosis in three
patients.
Sputum samples were helpful in establishing the diagnosis
in two patients with pneumonia. Two patients were consid-
ered false-positive. Among 28 positive culture results, 12
contributed to the FUO diagnosis.
Imaging techniques
A chest X-ray was obtained from all patients and contrib-
uted to the diagnosis in 13 patients, leading the clinicians
to more specific diagnostic approaches. Although chest X-
ray is not diagnostically instructive in the evaluation of
FUO,12 this test was performed as an initial diagnostic test
within the first three days of hospitalization when the
patient was not categorized as an FUO case. Tuberculosis
(8), pneumonia (3), Hodgkin lymphoma (1), and sarcoidosis
(1) were detected as the final diagnoses in these
patients.
Ultrasound (US) was performed in 141 patients. US
contributed to diagnosis in seven patients: hepatic abscess
(2), retroperitoneal abscess (1), liver metastasis (1),
hypernephroma (1), pyelonephritis (1), and splenic lym-
phoma (1). Abdominal computerized tomography (ACT)was performed in 98 patients and contributed to the
diagnosis in 10 patients: solid cancer (3; hepatoma, pan-
creas cancer, hypernephroma), hepatic abscess (2), retro-
peritoneal abscess (1), pelvic abscess (1), liver metastasis
(1), splenic lymphoma (1), multiple myeloma (1). Thorax
computerized tomography (TCT) was performed in 82
patients. TCT contributed to diagnosis in five patients:
sarcoidosis, pneumonia, tuberculosis, lymphoma, intersti-
tial pulmonary fibrosis (one patient each). Trans-thoracic
echocardiography (TTE) was performed in 82 patients. TTE
contributed to the diagnosis of two patients (tuberculous
pericarditis, infective endocarditis). Brain computerized
tomography (BCT) was performed in 20 patients. BCT
contributed to the diagnosis of two patients: cerebral
infarction (vasculitis case) and neurobrucellosis. Colono-
graphy with barium enema (n = 15) contributed to diag-
noses in two patients: colon carcinoma and ulcerative
colitis. Intravenous pyelography (n = 5) contributed to only
one diagnosis: ureteral obstruction in pelvic abscesses.
Doppler ultrasound (n = 10) contributed to the diagnosis
in only one patient: venous thrombosis.
Six hundred and seven radiological tests were per-
formed; of these tests, 43 contributed to the diagnosis.
One hundred and forty-one tests were considered as ‘non-
contributing’.
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Figure 1 Mean values of fever in the infectious diseases (ID)
and other non-infectious groups.
Figure 2 Median leukocyte counts in the infectious diseases
(ID) and malignant diseases (MD) groups.
Table 4 Diagnostic values of the histologic techniques
Histologic techniques (positive/total) Final diagnosis
Lymph node biopsy (9/20) Tuberculosis lymphadenitis (5)
Lymphoma (3)
Castleman disease (1)
Thyroid biopsy (3/8) Subacute thyroiditis (3)
Bone marrow aspiration (2/5) Chronic myelocytic leukemia (1)
Multiple myeloma (1)
Bone marrow biopsy (5/17) Multiple myeloma (1)
Acute myeloid leukemia (1)
Lymphoma (2)
Myeloid syndrome (1)
Liver biopsy (5/14) Granulomatous hepatitis (2)
Hepatoma (1)
Metastatic adenocarcinoma (1)
Candida infection (1)
Skin biopsy (3/12) Henoch—Scho¨nlein purpura (1)
Dermatomyositis (1)
Hypersensitivity vasculitis (1)
Temporal artery biopsy (4/16) Temporal arteritis (4)
Upper gastrointestinal endoscopy and/or colonoscopy with biopsy (2/41) Gastric carcinoma (1)
Colon carcinoma (1)
Pancreatic biopsy (1/2) Pancreatic carcinoma (1)
Renal biopsy (1/1) Hypernephroma (1)
Peritoneal biopsy (1/1) Tuberculosis peritonitis (1)
Pleural biopsy (1/1) Pleura tuberculosis (1)
Lumbar puncture (1/12) Meningitis (1)
Thorasynthesis, pericardiosynthesis and/or parasynthesis (3/19) Tuberculosis (2)
Intra-abdominal abscesses (1)Histologic techniques
Histologic examinations were performed in 143 patients and
41 biopsies yielded results contributing to the diagnosis. Of
these, nine were obtained from lymph nodes, three from
thyroid gland, five from bone marrow, five from liver, three
from skin, and four from temporal artery biopsies (Table 4).
Compared to the other groups, the diagnostic utility of
culture results was significant in the ID group ( p = 0.001),
immunologic assessments were significant in the NIID group
( p = 0.02), and radiologic and histopathologic methods were
especially significant for the MD group ( p = 0.016 and
p = 0.002, respectively). The diagnostic utility of clinical
observations was significant in the NIID and MD patients
( p = 0.001 and p = 0.031, respectively).
The cause of FUO was diagnosed by non-invasive tech-
niques in 78 patients and by invasive procedures in 52
patients.
Infectious diseases (ID) group
The most common symptoms in the ID group were fatigue,
chills, weight loss, nausea, and headache. The most com-
monly observed physical examination findings were cardiac
murmur, hepatomegaly, and lymphadenopathy. Nausea,
abdominal pain, and diarrhea complaints were common
compared to the other groups ( p < 0.05.). The mean level
of fever was 38.4  0.7 8C, and the fever level was found tobe significantly higher in the ID group compared to the other
groups at weeks 2 and 4 (Figure 1). In the MD group the
number of cases with leukocytosis increased in weeks 4—6,
but decreased in the ID group ( p = 0.013; Figure 2).
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tures in 10% of cases, by invasive procedures in 29% of cases,
and by serologic test results in 22% of cases. Themean time to
diagnose ID cases was 25  12 days and was significantly
shorter than in the other groups ( p = 0.05). In nine tubercu-
losis cases (42.9%), biopsy was diagnostic (five tuberculosis
lymphadenitis, two liver biopsies, one peritoneal and one
pleural biopsy). In six cases (28.6%), radiology plus clinical
findings (five chest X-rays, one pulmonary CT) were diagnos-
tic. In four cases (19.0%), positive acid resistant bacteria (one
blood, one urine, one sputum, one pleural fluid) was diag-
nostic, in one case echocardiography was diagnostic, and in
another case clinical observation plus treatment established
the diagnosis.
Among abscess cases, three were diagnosed by US (two
hepatic, one pelvic) and two by CT (one hepatic, one
retroperitoneal). The presence of concomitant diseases,
nausea, high-grade fever, higher respiration rate, and more
diarrheic complaints were independent risk factors for the
ID group.
Malignant diseases (MD) group
The most common symptoms in the MD group were fatigue,
weight loss, and tachycardia. The mean value of fever was
38.5  0.5 8C and the mean number of days with fever was
51  35. The number of days with fever was higher in the MD
group compared to the other groups ( p = 0.031). The median
leukocyte values were significantly higher than the values of
the infection group ( p < 0.005; Figure 2).
Mean CRP values were 29  49 in the MD patients. Com-
pared to the other groups, the CRP level was lower. Mean CRP
values continued a lower course also in the following weeks
( p < 0.05). All cases of solid cancer (n = 10) were diagnosed
by biopsy. In this group, the diagnostic utility of radiological
examinations and biopsy was high. The mean hemoglobin
level was low and the mean lactic dehydrogenase level was
higher. The mean total protein level was lower (6.2  0.7,
p = 0.039).
Non-infectious inflammatory diseases (NIID)
group
The most common symptoms in the NIID group were fatigue,
arthralgia, and myalgia. In this group, the percentages of
muscle pain and arthralgia, skin lesions and arthritis, and
pathologic findings on fundoscopic examination were higher.
Among laboratory findings, leukocytosis, elevated ESR, ele-
vated creatinine phosphokinase, ANA-positivity, and elevated
thyroid-stimulating hormone (TSH) were more common in this
group. Themean fever levelwas 38.2 0.7 8Cand the number
of days with fever was 28  24. When fever course was exam-
ined, the fever level in NIID patients was lower compared to
the other groups especially at week 4 (p = 0.018). In patients
diagnosed with NIID, independent risk factors were history of
previous disease and arthralgia. Compared to the other
groups, the mean leukocyte level was found to elevate sig-
nificantly more after the third week. The mean CRP level was
64.4 mg/dl in NIID patients. Compared to the other groups the
CRP levelwas found to behigher (p = 0.006). In theNIID group,
CRP levels were still higher after the second week, in contrast
to the other groups with a lower CRP course.Undiagnosed (U) group
In 24 of our cases (15.6%) no diagnosis could be established
that would explain FUO. The mean age of these cases was
50  17 years, significantly higher than in the other groups
( p = 0.028). The mean duration of follow-up in these patients
was 40  11 days. The most commonly observed symptoms in
the undiagnosed cases were fatigue, weight loss, tachycar-
dia, and cough. The most common physical finding was lymph
node enlargement. The mean leukocyte count of the cases
was lower compared to the mean counts of diagnosed
patients ( p = 0.022). Anemia was found in 87% of the undiag-
nosed patients and it was considerably higher compared to
the diagnosed patients (61%) ( p = 0.012). Tachycardia,
cough, and lymphadenopathy were independent risk factors
in the undiagnosed group. In the undiagnosed group, 8% of
the cases were <30 years old and 33% were over 60. The
corresponding percentages were 35% and 17% ( p = 0.007) in
the diagnosed group.
Discussion
In most collected FUO series, infection has been the most
common diagnosis overall, accounting for 25—50% of cases.
Among the infections responsible for FUO, tuberculosis,
abscesses, endocarditis, and complicated urinary tract infec-
tions have consistently been among the most important.13,14
The relative frequency by which the major diagnostic cate-
gories are represented in series of classic FUO, varies accord-
ing to both the era in which the series was published and its
country of origin;15 for example, Kikuchi—Fujimoto disease,
an unusual form of necrotizing lymphadenitis seen primarily
in Japan, and familial Hibernian fever, an inherited periodic
fever syndrome described mostly in Ireland.16,17
Since the mid-1900s, the frequencies of infections and
malignant neoplasms identified as causes of classic FUO have
fallen steadily, whereas the proportion of miscellaneous
causes and undiagnosed conditions has risen.18 However, in
developing countries, there has been little change in the
frequency of diagnosis of infections. Deficient sanitary mea-
sures may be important factors in developing countries.
Consequently, malignant neoplasms and connective tissue
disorders are comparatively less important as causes of
classic FUO than in developed countries. In our country,
infections have traditionally been the most important causes
of FUO.19
This is the first prospective and multicenter study in
Turkey, although several studies have reported the preva-
lence and causes of FUO. Infectious diseases have been the
leading causes in the etiology of FUO and seem to have been
decreasing since the first publication. Tuberculosis, brucel-
losis, and salmonellosis have decreased as well, while CMV
infections have increased possibly due to advancing medic-
inal services in the management of chronic diseases and
underlying pathologies.
When all Turkish FUO studies are taken into account,
tuberculosis, which remains one of the deadliest diseases
in the world, is still the leading infection among the trans-
missible causes of FUO in our country (Table 5).19—26 The
same is also valid in this present study in which half of the
cases were in themiliary form emphasizing that the disease is
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Table 5 Etiologic spectrum of the FUO cases over three periods of study in Turkey
Year Total number
of cases
Reference No. ID % NIID % MD % Mi % U %
First period 1984 70 26 64 10 11 10 4
Second period 1984—2002 491 19—25 50 14 16 5 14
Present study 2004 154 34 31 14 5 16
ID, infectious diseases; NIID, non-infectious inflammatory diseases; MD, malignant diseases; Mi, miscellaneous; U, undiagnosed.diagnosed in the latter stages. TheWorld Health Organization
estimates that each yearmore than eightmillion new cases of
tuberculosis occur.27 Ninety-five percent of tuberculosis
cases occur in developing countries, where the disease goes
undiagnosed due to deficient capabilities.28 Despite the
enormous global burden of the disease and the overall low
rates of case detection worldwide, conventional approaches
for diagnosis have relied on tests that have major limitations.
For example, sputum smearmicroscopy is insensitive; culture
is technically complex and slow; determination of drug sus-
ceptibility is even more technically complex and slower yet;
chest radiography is non-specific; and tuberculin skin testing
is imprecise, and the results are often non-specific.29 Con-
sequently, owing to insufficient diagnosis when compared
with other bacterial infections, tuberculosis frequently falls
into the FUO category as in Turkey. In contrast, brucellosis,
once reported to be the one of the leading causes of FUO,24
has declined over the course of time probably due to easier
diagnostic capabilities compared with tuberculosis. Thus,
infections on the whole have shown a decrease within the
FUO etiology in recent years, but the frequency of tubercu-
losis has not actually declined.
Our review of the literature revealed that the proportion of
FUOcasesgrouped into specificdiseasecategorieshas changed
during the past decades.19—26 Infections have been the most
important causes of FUO in nearly all reports including this
study, with a relative frequency ranging from 64% to 50%.
Turkish studies, including this one, show that the proportion of
infectious diseases has steadily decreased in the past decades,
although tuberculosis is the most common infection in our
country. This trend may be attributed to the use of rapid
diagnostic tests, invasive procedures, and developed imaging
techniques all of which can be interpreted with the improving
capabilities of the healthcare system. Consequently, infec-
tions are diagnosed at earlier stages and prolonged febrile
illnesses without established etiologies despite intensive eva-
luation and diagnostic testing are confined to hard-to-detect
transmissible diseases like tuberculosis.
The second greatest cause of FUO was NIID (30.5%) in our
trial. Other studies have reported rates around 10—14%.19—26
Adult Still’s disease was found to be the leading etiology of
FUO in the group of NIID and comprised approximately 14% of
all the cases. In other series, SLE and temporal arteritis have
been the most common disorders. Compared to the previous
studies, the proportion of NIID has steadily increased.
However, the nature of NIID varies in our country. A rapid
immunologic diagnosis by using an assay of antinuclear and
anti-DNA antibody can be used to diagnose SLE. On the other
hand, adult Still’s disease is accompanied by high-grade fever
and systemic symptoms, and is a common cause of FUO.
However, the clinical signs, symptoms, and diagnosis of adult
Still’s disease are still more complex compared to SLE andtemporal arteritis. Despite rich symptoms, signs, and labora-
tory findings, these are non-specific findings and are usually
non-diagnostic. The diagnosis of this disease is usually made
following elimination of other diseases that take place in the
differential diagnosis. This is the reason for the delay in
diagnosing patients with Still’s disease and might explain
why the proportion of the disease as a cause of FUO has
been increasing over time.
The frequency of malignant diseases in our trial, which
accounted for 14.3% of FUO, is comparable to that found in
previous studies varying between 11.7% and 17%. These
similar results suggest that patients with tumors are probably
recognized thanks to the widespread use of radioimaging
techniques in most Turkish hospitals, and thus the proportion
of neoplasms associated with FUO has not changed.
It is difficult to explain why the number of undiagnosed
cases remains high in our study. Several possible factors may
have played a role. The application of intensive and aggres-
sive medical treatments in the early phases of disease,
especially in patients who are referred from primary and
secondary healthcare facilities to tertiary hospitals, could be
the cause of equivocal clinical and laboratory findings. Higher
frequencies of advanced age and anemia in the undiagnosed
cases suggest that some of them might be malignant diseases
or NIID cases such as temporal arteritis, which could be
difficult to diagnose due to limited diagnostic resources.
Among the total tests, positive result rates were low for
both immunologic serology and microbiologic serology tests
(12.8%, 4.2%). However, the diagnostic significance of these
tests among positives was high (40%, 53%). Microbiologic
serology tests had a diagnostic significance of 30% in the ID
group and immunologic serology tests had a diagnostic sig-
nificance of 17% in the NIID group.
CRP is one of the acute phase reactants. Contrary to
expectations, in our ID cases, CRP levels were not high
compared to other groups. Decreasing CRP levels in the ID
group started from the first week and a lack of substantial
change during the subsequent days may be associated with
antibiotic use. CRP levels remained quite high in the NIID
group at weeks one and four. The decrease in CRP levels in our
cases during the second and third weeks and its fluctuated
course might be associated with disease activation or med-
ications used. Leukocyte values were higher in the ID and MD
groups compared to the other groups. These elevated levels
were more striking especially in the MD group during the first
four weeks compared to the ID group. These elevations were
significant in the NIID group especially after the second week
and remained high compared to other groups.
For imaging techniques, our possibility of obtaining posi-
tive results was high and these techniques had a diagnostic
value in only a quarter of cases with positive findings. These
results suggest that positive findings obtained by imaging
The spectrum of diseases causing FUO in Turkey 79techniques have a low rate of contribution to FUO etiology.
Nonetheless, when all groups were evaluated, it was seen
that imaging methods had diagnostic value in a substantial
percentage of MD (54%) and ID (47%) cases, and they were
indispensable diagnostic methods for monitoring FUO cases.
Our study results show that imaging techniques made a small
contribution to the diagnosis in the NIID group (11%).
The FUO definitions include epidemiological controver-
sies.30 Evolving from a one-week stay in hospital to three
outpatient visits or three days of hospital stay as suggested by
Durack and Street has made the definition even more biased.
Pre-hospital healthcare facilities vary between countries,
and even within a country depending on the referral sys-
tem.31 Our study results demonstrate that the mean time to
definite diagnosis in all of our cases was 32  18 days and this
suggests that the Petersdorf and Beeson criteria should still
be applicable for FUO identification in developing countries
such as Turkey.
In conclusion, the spectrum of diseases causing FUO in
Turkey continues to change. Infection remains the most
common cause and the high percentage of cases with tuber-
culosis points to the fact that we should be aware of tuber-
culosis as a likely cause of FUO. The proportion of NIID has
been increasing, possibly due to improving living conditions
throughout the country by reducing the proportion of infec-
tions. However, further studies conducted in different geo-
graphic locations with prospective and multicenter designs
are needed to track the changing etiology of FUO and facil-
itate its early diagnosis and appropriate management.
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